BELLWAVE-010: A phase 3 study of nemtabrutinib plus venetoclax versus venetoclax plus rituximab (VR) in previously treated patients (pts) with relapsed/refractory (R/R) chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL).

---

Ozcan M., Lavie D., Chaudhry A., Zhou X., Paydar I., Farooqui M. Z. H., ...Daha Fazla

JOURNAL OF CLINICAL ONCOLOGY, sa.16, 2024 (SCI-Expanded, Scopus)

• Yayın Türü: Makale / Özet
• Basım Tarihi: 2024
• Dergi Adı: JOURNAL OF CLINICAL ONCOLOGY
• Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, PASCAL, CAB Abstracts, CINAHL, Gender Studies Database, International Pharmaceutical Abstracts, Veterinary Science Database
• Ankara Üniversitesi Adresli: Evet